You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博雅生物(300294.SZ):擬將廣東復大醫藥75%的股權轉讓給華潤醫商
格隆匯 09-01 20:40

格隆匯9月1日丨博雅生物(300294.SZ)公佈,公司為進一步聚焦血液製品主業,於2021年9月1日與公司第一大股東華潤醫藥控股有限公司(“華潤醫藥控股”)之控股子公司華潤醫藥商業集團有限公司(“華潤醫商”)簽訂《股權轉讓框架協議》,擬將持有的廣東復大醫藥有限公司(“標的公司”)75%的股權轉讓給華潤醫商。

鑑於華潤醫藥控股將通過認購公司2020年向特定對象發行的股份成為公司的控股股東,華潤醫商為華潤醫藥控股的控股子公司,根據《深圳證券交易所創業板股票上市規則》第7.2.6條、第7.2.3條的規定,華潤醫商為公司的關聯方,公司向其轉讓持有的標的公司股權將構成關聯交易。

在華潤醫商與公司簽訂正式的股權轉讓協議時,公司將按照《股票上市規則》及《博雅生物製藥集團股份有限公司章程》的規定履行關聯交易的審議程序並進行信息披露。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account